Helping Deep Tech Founders build world-changing companies from ground-breaking discoveries.

Investing in Scientific Innovation

Blue Bear Ventures (BBV) engages founders working on the frontiers of science and technology with the potential to solve some of the most pressing challenges we face in the world today.

Deep Software & AI

Robotics

Gene Therapy

Advanced Manufacturing

Semiconductors

Synthetic Biology

Energy & Environment

Novel Materials

Technologies at the Intersection of Disciplines

Our Philosophy

Founding Team

The most important aspect of our deep tech companies are the founding teams. We’re not investing in just an idea and a single founder – we’re investing in the co-founding team and the early employees that help a company through its growth. For a company to make an impact, it must be surrounded by individuals with the right combination of technical skills and entrepreneurial spirit.

Building Trust

BBV builds strong relationships with companies we invest in based on trust. We are not traditional investors that just look at metrics, but are also confidants who help the founders and team. We advise our companies in all areas from the earliest stages so they can focus on their ultimate goal of bringing their breakthrough technologies to the world.

The Journey

The journey of climbing a mountain is non-linear. Our objective is to guide our companies through the peaks and valleys while helping them making the right choices with conviction. We are not the authorities in directing founders along their path – we leave that to the founders. Instead, we see ourselves as part of the companies team, providing clarity along the way. We are with our companies through their entire journey. Not just the beginning.

Our Startups

Our founders are scientists and engineers from the top research institutions in the world. They have founded some of the most promising deep technology startups emerging from UC Berkeley, UC San Francisco, UC Santa Cruz, MIT, and Stanford.

  • Aether Bio

    Engineering enzymes for biological manufacturing using deep learning and high-throughput robotics. Santa Cruz

  • Aluna

    Smart respiratory health management system for patients with asthma and chronic respiratory diseases. UCSF Berkeley

  • Ayar Labs

    Helping companies keep up with skyrocketing volumes of data by miniaturizing fiber optic transceivers. Berkeley MIT

  • Clarity

    Providing high density air quality monitoring solutions for smart cities. Berkeley

  • Coreshell

    Engineering novel, liquid-deposited nanolayer coatings for Lithium Ion Batteries to enable cheaper and faster battery production. Berkeley

  • Correlia Biosystems

    Next-generation high-throughput protein assays for pharmaceutical applications. Berkeley

  • DNA Lite

    Developing oral and non-immunogenic gene therapies delivered to the gastrointestinal tract. Berkeley

  • EngageLively

    Making it easy for everyone to create dynamic, interactive and portable content. Berkeley

  • GenEdit

    Transforming the delivery of gene therapies and enable the next generation of non-viral, gene editing-based therapeutics. Berkeley

  • ImpriMed

    Precision medicine for pet cancer patients by identifying personalized drug combinations. Stanford

  • mFluidx

    Rapid DNA tests for infectious disease diagnostics. Berkeley

  • New Sun Road

    Providing modular smart micro grid management solutions for energy infrastructure in the developing world. Berkeley

  • Numericcal

    Enabling the deployment, optimization and management of Deep Neural Network Models for edge computing. Berkeley MIT

  • SF17

    Building new drugs to target inflammation directly from patients using an AI + Immunology discovery engine. UCSF

  • Unnatural Products

    Drug discovery platform accelerating early stage drug discovery of macrocyclic peptide therapeutics. Santa Cruz

  • Xinampa

    Building the largest sustainable energy marketplace in Latin America using IoT and AI enabled data streams. Berkeley

  • YourChoice Therapeutics

    Revolutionizing birth control for women and men by developing hormone free contraceptives. Berkeley

  • BioAmp Diagnostics

    Rapid diagnostics to counteract antibiotic resistance and empower physicians to treat patients with the right antibiotic at the right time. Berkeley

  • Immulus

    Next generation biomanufacture of cell therapies. Harvard

The Team

As a team of investors, entrepreneurs and technologists, we are driven to help entrepreneurs build world-changing companies from their ground-breaking discoveries.

 

Building on our success from operating the CITRIS Foundry startup accelerator at UC Berkeley since 2013, we’re moved to found BBV because of the incredible technology and talent we have seen in the UC Berkeley community. Through our unique relationship with the University, we’re excited to provide a smoother startup path and expert guidance to deep tech entrepreneurs.
patrick-scaglia2-crop

Patrick brings 35+ years of technology management and investment experience to BBV. He is currently or has previously served on the boards of YC Research, CITRIS, UC Berkeley College of Eng., Audience (NASDAQ:ADNC) and several venture-backed startups. Patrick previously spent 26 years in CTO and sr. exec positions at HP (NYSE:HPQ), Cadence Design (NASDAQ:CDNS) and multiple computing technology startups.

Patrick Scaglia

Managing Partner
Foundry_Spring_Cohort_2018_Photos

Deepak advises entrepreneurs at the UC Berkeley Haas Business school and is a mentor at various accelerators in Silicon Valley. He has 10 years of venture investing experience across 3 institutional funds. Prior to investing, he was part of 4 medical startups as either an entrepreneur or in management roles, having an exit with Cepheid (NASDAQ:CHPD), a molecular diagnostic company.

Deepak Gupta

Managing Partner
Alic Chen Headshot Square Crop

Alic co-founded CITRIS Foundry shortly after receiving his Ph.D. in Mech. Engineering from UC Berkeley in 2012 and has been growing a diverse portfolio of startups that develop technologies ranging from health and therapeutics to novel sensors and AI. Over the last 6 years, he has advised 50+ science and technology startups, 68% of which have cumulatively raised $100M+ in funding since joining the program.

Alic Chen

Partner

Get in Touch